Synovium-Derived Mesenchymal Stem Cell Transplantation in Cartilage Regeneration: A PRISMA Review of in vivo Studies
- PMID: 31803726
- PMCID: PMC6873960
- DOI: 10.3389/fbioe.2019.00314
Synovium-Derived Mesenchymal Stem Cell Transplantation in Cartilage Regeneration: A PRISMA Review of in vivo Studies
Abstract
Articular cartilage damaged through trauma or disease has a limited ability to repair. Untreated, focal lesions progress to generalized changes including osteoarthritis. Musculoskeletal disorders including osteoarthritis are the most significant contributor to disability globally. There is increasing interest in the use of mesenchymal stem cells (MSCs) for the treatment of focal chondral lesions. There is some evidence to suggest that the tissue type from which MSCs are harvested play a role in determining their ability to regenerate cartilage in vitro and in vivo. In humans, MSCs derived from synovial tissue may have superior chondrogenic potential. We carried out a systematic literature review on the effectiveness of synovium-derived MSCs (sMSCs) in cartilage regeneration in in vivo studies in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. Twenty studies were included in our review; four examined the use of human sMSCs and 16 were conducted using sMSCs harvested from animals. Most studies reported successful cartilage repair with sMSC transplantation despite the variability of animals, cell harvesting techniques, methods of delivery, and outcome measures. We conclude that sMSC transplantation holds promise as a treatment option for focal cartilage defects. We believe that defining the cell population being used, establishing standardized methods for MSC delivery, and the use of objective outcome measures should enable future high quality studies such as randomized controlled clinical trials to provide the evidence needed to manage chondral lesions optimally.
Keywords: cartilage repair; mesenchymal stem cells; osteoarthritis; synovium; transplantation.
Copyright © 2019 To, Zhang, Romain, Mak and Khan.
Figures
Similar articles
-
Use of human induced pluripotent stem cells for cartilage regeneration in vitro and within chondral defect models of knee joint cartilage in vivo: a Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic literature review.Cytotherapy. 2021 Aug;23(8):647-661. doi: 10.1016/j.jcyt.2021.03.008. Epub 2021 May 29. Cytotherapy. 2021. PMID: 34059422 Review.
-
Platelet-Derived Microparticles Mediate the Intra-Articular Homing of Mesenchymal Stem Cells in Early-Stage Cartilage Lesions.Stem Cells Dev. 2020 Apr 1;29(7):414-424. doi: 10.1089/scd.2019.0137. Epub 2020 Mar 12. Stem Cells Dev. 2020. PMID: 32000580
-
Regenerative Potential of Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis and Chondral Defects: A Systematic Review and Meta-analysis.Arthroscopy. 2021 Jan;37(1):362-378. doi: 10.1016/j.arthro.2020.05.037. Epub 2020 Jun 1. Arthroscopy. 2021. PMID: 32497658
-
The Potential for Synovium-derived Stem Cells in Cartilage Repair.Curr Stem Cell Res Ther. 2018 Feb 23;13(3):174-184. doi: 10.2174/1574888X12666171002111026. Curr Stem Cell Res Ther. 2018. PMID: 28969580 Review.
-
Cartilage regeneration using arthroscopic flushing fluid-derived mesenchymal stem cells encapsulated in a one-step rapid cross-linked hydrogel.Acta Biomater. 2018 Oct 1;79:202-215. doi: 10.1016/j.actbio.2018.08.029. Epub 2018 Aug 28. Acta Biomater. 2018. PMID: 30165202 Free PMC article.
Cited by
-
Synovium Derived Mesenchymal Stromal Cells (Sy-MSCs): A Promising Therapeutic Paradigm in the Management of Knee Osteoarthritis.Indian J Orthop. 2021 Jun 10;56(1):1-15. doi: 10.1007/s43465-021-00439-w. eCollection 2022 Jan. Indian J Orthop. 2021. PMID: 35070137 Free PMC article. Review.
-
Regeneration of articular cartilage defects: Therapeutic strategies and perspectives.J Tissue Eng. 2023 Mar 31;14:20417314231164765. doi: 10.1177/20417314231164765. eCollection 2023 Jan-Dec. J Tissue Eng. 2023. PMID: 37025158 Free PMC article. Review.
-
Hemovac blood after total knee arthroplasty as a source of stem cells.Ann Transl Med. 2020 Nov;8(21):1406. doi: 10.21037/atm-20-2215. Ann Transl Med. 2020. PMID: 33313151 Free PMC article.
-
Efficacy and Safety of Intra-Articular Cell-Based Therapy for Osteoarthritis: Systematic Review and Network Meta-Analysis.Cartilage. 2021 Dec;13(1_suppl):104S-115S. doi: 10.1177/1947603520942947. Epub 2020 Jul 22. Cartilage. 2021. PMID: 32693632 Free PMC article.
-
Synovial membrane mesenchymal stem cells for cartilaginous tissues repair.Mol Biol Rep. 2022 Mar;49(3):2503-2517. doi: 10.1007/s11033-021-07051-z. Epub 2022 Jan 11. Mol Biol Rep. 2022. PMID: 35013859 Review.
References
-
- Akiyama H., Chaboissier M.-C., Martin J. F., Schedl A., de Crombrugghe B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813–2828. 10.1101/gad.1017802 - DOI - PMC - PubMed
-
- Ando W., Tateishi K., Hart D. A., Katakai D., Tanaka Y., Nakata K., et al. . (2007). Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28, 5462–5470. 10.1016/j.biomaterials.2007.08.030 - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources